Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0786 per EA under NDC 63304072390. Its NADAC has been published 260 times since Mar 3, 2021.
FDA first approved this application on Nov 30, 2020.
Strength
150 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304072390
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200216FDA Approved
11/30/2020
On Market Since
12/9/2020
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 260 times since Mar 3, 2021, and over the history we have for it it has declined 54.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0786 per EA |
|---|---|
| All-time high | $0.1807 (Jun 16, 2021) |
| All-time low | $0.0745 (Nov 20, 2024) |
| 52-week high | $0.1015 |
| 52-week low | $0.0786 |
| Median price | $0.1059 |
| Average price | $0.1159 |
| Largest weekly change | -30.3% (Nov 20, 2024) |
| Weeks tracked | 260 |
| Tracking since | Mar 3, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-22.6%
3Y
-22.3%
5Y
-49.7%
All
-54.2%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.0786 per EA (NDC 63304072390), effective Feb 18, 2026.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 54.2%. It has been tracked across 260 weekly CMS publications since Mar 3, 2021.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Mar 3, 2021, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.1807 (Jun 16, 2021), with a median of $0.1059 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 63304072390) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.